Protective effects of recombinant human growth hormone on cirrhotic rats

doi:10.3748/wjg.v10.i19.2894

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2544)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

256

HTML

1946

Figures (1-2)

184

Tables (1-1)

158

Sum=2544

Oct 1, 2004 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Oct 1, 2004; 10(19): 2894-2897
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2894

Open in New Tab Full Size Figure Download Figure

Figure 1 Expression of GHR mRNA in normal and cirrhotic liver tissues after NS or rhGH administration. Lane 1: control group +NS (group A); Lane 2: control group +rhGH (group B); Lane 3: cirrhotic group +NS (group C); Lane 4: cirrhotic group +rhGH (group D); and Lane M: DNA standard marker of 100, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1100 and 1200 bp, respectively.

Open in New Tab Full Size Figure Download Figure

Figure 2 Correlation analysis of SOD and MDA.

Citation: Chen S, Wang HT, Yang B, Fu YR, Ou QJ. Protective effects of recombinant human growth hormone on cirrhotic rats. World J Gastroenterol 2004; 10(19): 2894-2897
URL: https://www.wjgnet.com/1007-9327/full/v10/i19/2894.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i19.2894